MICHELLE DOUBLE: Open Payments
NPI 1902393002 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 31 payments from 12 companies in 2025. Trend: 2023 $1,230 · 2024 $807 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $166 |
| ABBVIE INC. | 5 | $121 |
| Amgen Inc. | 5 | $97 |
| Exact Sciences Corporation | 4 | $93 |
| Abbott Laboratories | 3 | $69 |
| Lilly USA, LLC | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: Ozempic, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, OTEZLA, VRAYLAR, MOUNJARO, REXULTI, REPATHA.
Industry payments across FL — which companies pay providers there.
